What is MCIBD: Multidisciplinary Care for IBD conference series?
MCIBD is a Continuing Health Education initiative for the Northern Alberta physicians and health care providers who manage IBD. MCIBD is a series of conferences started in 2016, with the aim is to facilitate collaboration and exchange of evidence-based strategies and guidelines to use in clinical practice. Each year, a different topic is selected and guest speakers invited from local and provincial areas.
The Third Annual MCIBD conference will be held on September 29, 2018 at Sheraton Downtown Toronto. This year the objectives include:
- Reviewing the importance of multi-disciplinary care for women with IBD planning a pregnancy
- Discuss the medical and surgical management of IBD during preconception, pregnancy, and peripartum
- Consider practical considerations regarding nutrition, delivery and breast feeding for women with IBD
This year the conference will invite physicians (gastroenterologists, general practitioners/family doctors, surgeons, obstetricians and gynecologists, obstetrical internists, nurses, pharmacists, social workers, dietitians, allied health providers).
Our international guest speaker is Dr. Van Der Woude, from Rotterdam, a renowned world famous IBD expert who specializes in the management of IBD preconception through to post partum.
The event will be sponsored by several pharmaceutical companies (AbbVie, Ferring, Merck, Pfizer, Shire, Takeda).
Mind and Gut: The conundrum of chronic illness
The second MCIBD conference was held on June 10, 2017 at Lister Hall, University of Alberta. This conference focused on the interactions between chronic illness such as IBD and mental health. The conference included a series of interactive seminars, and workshops, led by expert clinicians in IBD management, psychiatry, psychology, nursing and alternative medicine. More than 40 physicians, nurses, and allied health professionals involved in the care of men and women with IBD attended the educational event. The event was sponsored by U of A FOMD, and several pharmaceutical companies (Abbvie, Janssen, Takeda, Merck, Ferring, Shire).
Managing IBD During Pregnancy, Evidence-based Strategies & Guidelines to use in Clinical Practice – “Strength through shared knowledge”
The first MCIBD conference was held March 12, 2016 at Royal Mayfair Golf Club. The conference included a series of interactive seminars, and workshops, led by expert clinicians in IBD management, maternal fetal medicine, obstetrics, general surgery, IBD nursing care, and dietician. More than 40 physicians, nurses, and allied health professionals involved in the care of men and women with IBD attended the educational event. The event was sponsored by AIHS, U of A FOMD, and several pharmaceutical companies (Abbvie, Janssen, Takeda, Ferring, Shire). Attendees were provided copies of the newly published Toronto Consensus Statements on the Management of IBD During Pregnancy, as well as the opportunity to meet experts in the field and ask questions.